Covid vaccines do not increase risk of adverse events, claims Study

COVID-19 vaccines did not cause an increased risk of adverse events such as heart attack, stroke, cardiac arrest, myocarditis, pericarditis, and deep vein thrombosis, according to a study.

Coronavirus, Covid-19
Photo: Bloomberg
Press Trust of India London
3 min read Last Updated : Feb 10 2023 | 5:02 PM IST

COVID-19 vaccines did not cause an increased risk of adverse events such as heart attack, stroke, cardiac arrest, myocarditis, pericarditis, and deep vein thrombosis, according to a study.

The research, published in the journal Vaccines, monitored the entire population of the Italian province of Pescara for 18 months, from January 2021 to July 2022.

The team led by researchers from the University of Bologna in Italy collected inhabitants' health data and analysed the frequency of a number of serious diseases such as cardiovascular disease, pulmonary embolism and thrombosis.

Pulmonary embolism is a blood clot that blocks and stops blood flow to an artery in the lung while thrombosis occurs when blood clots block veins or arteries. The study showed that none of the diseases examined were found to be more frequent among the vaccinated than among the non-vaccinated.

"The results obtained clearly show that there was no increased risk of serious diseases among the vaccinated," said Lamberto Manzoli, a professor at the University of Bologna.

"There were isolated adverse cases, but the safety profile of the vaccines used during the pandemic was confirmed: it is now important to continue the follow-up over a longer period," Manzoli said.

The study is currently the only one in the world that monitored the population for more than a year, taking into account numerous factors including age, gender and clinical risk of the participants.

More specifically, the results obtained show that both deaths registered and the occurrence of the diseases examined were less frequent among vaccinated persons, regardless of gender, age and clinical risk profile.

The analysis also confirmed that vaccinated persons who contracted COVID-19 were more protected against the coronavirus than those who recovered after contracting the disease but were not vaccinated.

A higher incidence of the diseases considered was found among those who had not contracted COVID-19 and had only one or two doses of the vaccine, compared to those who had three or more doses, the researchers said.

"This counterintuitive finding is due to an epidemiological bias caused by the restrictions implemented during the emergency," Manzoli.

The data gathered show that 83.2 per cent of the vaccinated population who did not contract COVID-19 received at least three doses of vaccine.

"Those who received only one or two doses did not complete the vaccination cycle either because they died or because they were deterred by the onset of a disease," the scientist added.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Subscribe to Business Standard digital and get complimentary access to The New York Times

Quarterly Starter

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

Save 46%

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Access to Exclusive Premium Stories Online

  • Over 30 behind the paywall stories daily, handpicked by our editors for subscribers

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronaviruscoronaCoronavirus Vaccine

First Published: Feb 10 2023 | 5:02 PM IST

Next Story